Effects of procainamide on the excitable gap composition in common human atrial flutter

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 3, 1998, Pages 528-535

  Jalil, Elise ^a   Le Franc, Pierre ^a   Lebeau, Réal ^a   Molin, Franck ^a   Costi, Paolo ^a   Kús, Teresa ^a,b  

^a Centre de Recherche Hopital Du Sacre Coeur de Montreal   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Atrial flutter; Excitable gap; Procainamide; Reset response curve

Indexed keywords

ANTIARRHYTHMIC AGENT; DIGOXIN; DILTIAZEM; PROCAINAMIDE; PROPRANOLOL;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HUMAN; MALE;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROCAINAMIDE; TREATMENT OUTCOME;

EID: 0031967819     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb00094.x     Document Type: Article

References (23)

1. Feld GK, Fleck P, Chen PS, et al. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter: Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation 1992; 86:1233-1240.
2. Cosio FG, Arribas F, López-Gil M, et al. Endocardial catheter mapping of atrial arrhythmias. In M Shenasa, M Borggrefe, G Breithardt (eds.): Cardiac Mapping. Mount Kisco, NY, Futura Publishing Co., Inc., 1993, pp. 443-459.
3. Olshansky B, Okumura K, Hess P, et al. Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm. J Am Coll Cardiol 1988; 11:359-364.
4. Vaughan Williams EM, Szekeres L. A comparison of tests of antifibrillatory action. Br J Pharmacol 1961; 17:424-432.
5. Strauss HC, Saroff AL, Bigger JT, et al. Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man. Circulation 1973; 47:86-93.
6. Almendral JM, Stamato NJ, Rosenthal ME, et al. Resetting response patterns during sustained ventricular tachycardia: Relationship to the excitable gap. Circulation 1986; 4:722-730.
7. Callans DJ, Hook BG, Josephson ME. Comparison of resetting and entrainment of uniform sustained ventricular tachycardia: Further insights into the characteristics of the excitable gap. Circulation 1993; 87:1229-1238.
8. Rosenthal ME, Stamato NJ, Almendral JM, et al. Influence of the site of stimulation on the resetting phenomenon in ventricular tachycardia. Am J Cardiol 1986; 58:970-976.
9. Stamato NJ, Rosenthal ME, Almendral JM, et al. The resetting response of ventricular tachycardia to single and double extrastimuli: Implications for an excitable gap. Am J Cardiol 1987; 60:596-601.
10. Stamato NJ, Frame LH, Rosenthal ME, et al. Procainamide-induced slowing of ventricular tachycardia with insights from analysis of resetting response patterns. Am J Cardiol 1989; 63:1455-1461.
11. Della Bella P, Marenzi G, Tondo C, et al. Usefulness of excitable gap and pattern of resetting in atrial flutter for determining reentry circuit location. Am J Cardiol 1991; 68:492-497.
12. Derakhchan K, Pagé P, Lambert C, et al. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia. J Pharmacol Exp Ther 1994; 270:47-54.
13. Dangman KH, Hoffman BF. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of n-acetylprocainamide. J Pharmacol Exp Ther 1981; 217:851-862.
14. Atkinson AJ Jr, Ruo TI. Pharmacokinetics of N-acetylprocainamide. Angiology 1986; 37:959-967.
15. Okumura K, Waldo AL. Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: Comparison with the effects of quinidine. J Am Coll Cardiol 1987; 9:1332-1338.
16. Feld GK, Venkatesh N, Singh BN. Pharmacologic conversion and suppression of experimental canine atrial flutter: Differing effects of d-sotalol, quinidine and lidocaine and the significance of changes in refractoriness and conduction. Circulation 1986; 74:197-204.
17. Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study. J Am Coll Cardiol 1996; 28:130-136.
18. Stambler BS, Wood MA, Ellenbogen KA. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter overdrive pacing. Am J Cardiol 1996; 77:960-966.
19. Suttorp MJ, Kingma JH, Jessurun ER, et al. The value of Class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990; 16:1722-1727.
20. Wang Z, Pagé P, Nattel S. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992; 71:271-287.
21. Hohnloser SH, Zabel M. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Am J Cardiol 1992; 79:3A-10A.
22. Pietersen AH, Hellemann H. Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Am J Cardiol 1991; 67:713-717.
23. Rahme M, Lambert C, Kus T. Effects of flecainide on the excitable gap in canine atrial reentry tachycardia. Can J Physiol Pharmacol 1994; 72(Suppl. 1) 84.